Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1999 Jan 12;160(1):41–46.

Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data

J J Caro 1, J L Speckman 1, M Salas 1, G Raggio 1, J D Jackson 1
PMCID: PMC1229944  PMID: 9934342

Abstract

BACKGROUND: Rational medical decisions should be based on the best possible evidence. Clinical trial results, however, may not reflect conditions in actual practice. In hypertension, for example, trials indicate equivalent antihypertensive efficacy and safety for many medications, yet blood pressure frequently remains uncontrolled, perhaps owing to poor compliance. This paper examines the effect of initial choice of treatment on persistence with therapy in actual practice. METHODS: The authors examined all outpatient prescriptions for antihypertensive medications filled in Saskatchewan between 1989 and 1994 by over 22,000 patients with newly diagnosed hypertension whose initial treatment was with a diuretic, beta-blocker, calcium-channel blocker or angiotensin-converting-enzyme (ACE) inhibitor. Rates of persistence over the first year of treatment were compared. RESULTS: After 6 months, persistence with therapy was poor and differed according to the class of initial therapeutic agent: 80% for diuretics, 85% for beta-blockers, 86% for calcium-channel blockers and 89% for ACE inhibitors (p < 0.001). These differences remained significant when age, sex and health status in the previous year were controlled for. Changes in the therapeutic regimen were also associated with lack of persistence. INTERPRETATION: A relation not seen in clinical trials--between persistence with treatment and initial antihypertensive medication prescribed--was found in actual practice. This relation also indicates the importance of real-world studies for evidence-based medicine.

Full Text

The Full Text of this article is available as a PDF (131.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrade S. E., Walker A. M., Gottlieb L. K., Hollenberg N. K., Testa M. A., Saperia G. M., Platt R. Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med. 1995 Apr 27;332(17):1125–1131. doi: 10.1056/NEJM199504273321703. [DOI] [PubMed] [Google Scholar]
  2. Black D. M., Brand R. J., Greenlick M., Hughes G., Smith J. Compliance to treatment for hypertension in elderly patients: the SHEP pilot study. Systolic Hypertension in the Elderly Program. J Gerontol. 1987 Sep;42(5):552–557. doi: 10.1093/geronj/42.5.552. [DOI] [PubMed] [Google Scholar]
  3. Cooper J. K., Love D. W., Raffoul P. R. Intentional prescription nonadherence (noncompliance) by the elderly. J Am Geriatr Soc. 1982 May;30(5):329–333. doi: 10.1111/j.1532-5415.1982.tb05623.x. [DOI] [PubMed] [Google Scholar]
  4. Goldstein A. O., Carey T. S., Levis D., Madson S., Bernstein J. Variations in hypertension control in indigent rural primary care clinics in North Carolina. Arch Fam Med. 1994 Jun;3(6):514–519. doi: 10.1001/archfami.3.6.514. [DOI] [PubMed] [Google Scholar]
  5. Hamilton R. A., Briceland L. L. Use of prescription-refill records to assess patient compliance. Am J Hosp Pharm. 1992 Jul;49(7):1691–1696. [PubMed] [Google Scholar]
  6. Hershey J. C., Morton B. G., Davis J. B., Reichgott M. J. Patient compliance with antihypertensive medication. Am J Public Health. 1980 Oct;70(10):1081–1089. doi: 10.2105/ajph.70.10.1081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hiatt H., Goldman L. Making medicine more scientific. Nature. 1994 Sep 8;371(6493):100–100. doi: 10.1038/371100a0. [DOI] [PubMed] [Google Scholar]
  8. Jones J. K., Gorkin L., Lian J. F., Staffa J. A., Fletcher A. P. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ. 1995 Jul 29;311(7000):293–295. doi: 10.1136/bmj.311.7000.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mancia G., Sega R., Milesi C., Cesana G., Zanchetti A. Blood-pressure control in the hypertensive population. Lancet. 1997 Feb 15;349(9050):454–457. doi: 10.1016/s0140-6736(96)07099-7. [DOI] [PubMed] [Google Scholar]
  10. Marques-Vidal P., Tuomilehto J. Hypertension awareness, treatment and control in the community: is the 'rule of halves' still valid? J Hum Hypertens. 1997 Apr;11(4):213–220. doi: 10.1038/sj.jhh.1000426. [DOI] [PubMed] [Google Scholar]
  11. Monane M., Bohn R. L., Gurwitz J. H., Glynn R. J., Levin R., Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997 Jul;10(7 Pt 1):697–704. doi: 10.1016/s0895-7061(97)00056-3. [DOI] [PubMed] [Google Scholar]
  12. Neaton J. D., Grimm R. H., Jr, Prineas R. J., Stamler J., Grandits G. A., Elmer P. J., Cutler J. A., Flack J. M., Schoenberger J. A., McDonald R. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA. 1993 Aug 11;270(6):713–724. [PubMed] [Google Scholar]
  13. Nelson E. C., Stason W. B., Neutra R. R., Solomon H. S. Identification of the noncompliant hypertensive patient. Prev Med. 1980 Jul;9(4):504–517. doi: 10.1016/0091-7435(80)90045-6. [DOI] [PubMed] [Google Scholar]
  14. Ogilvie R. I., Burgess E. D., Cusson J. R., Feldman R. D., Leiter L. A., Myers M. G. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension. CMAJ. 1993 Sep 1;149(5):575–584. [PMC free article] [PubMed] [Google Scholar]
  15. Pierdomenico S. D., Mezzetti A., Lapenna D., Guglielmi M. D., Mancini M., Salvatore L., Antidormi T., Costantini F., Cuccurullo F. 'White-coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care. Eur Heart J. 1995 May;16(5):692–697. doi: 10.1093/oxfordjournals.eurheartj.a060975. [DOI] [PubMed] [Google Scholar]
  16. Rawson N. S., Malcolm E., D'Arcy C. Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles. Soc Psychiatry Psychiatr Epidemiol. 1997 May;32(4):191–199. doi: 10.1007/BF00788238. [DOI] [PubMed] [Google Scholar]
  17. Rawson N. S., Malcolm E. Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles. Stat Med. 1995 Dec 30;14(24):2627–2643. doi: 10.1002/sim.4780142404. [DOI] [PubMed] [Google Scholar]
  18. Reeves R. A. The rational clinical examination. Does this patient have hypertension? How to measure blood pressure. JAMA. 1995 Apr 19;273(15):1211–1218. doi: 10.1001/jama.273.15.1211. [DOI] [PubMed] [Google Scholar]
  19. Sharkness C. M., Snow D. A. The patient's view of hypertension and compliance. Am J Prev Med. 1992 May-Jun;8(3):141–146. [PubMed] [Google Scholar]
  20. Shea S., Misra D., Ehrlich M. H., Field L., Francis C. K. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health. 1992 Dec;82(12):1607–1612. doi: 10.2105/ajph.82.12.1607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sobel B. E., Furberg C. D. Surrogates, semantics, and sensible public policy. Circulation. 1997 Mar 18;95(6):1661–1663. doi: 10.1161/01.cir.95.6.1661. [DOI] [PubMed] [Google Scholar]
  22. Stockwell D. H., Madhavan S., Cohen H., Gibson G., Alderman M. H. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health. 1994 Nov;84(11):1768–1774. doi: 10.2105/ajph.84.11.1768. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES